{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:58:31Z","timestamp":1767895111193,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpba.2025.117243","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:26:11Z","timestamp":1763029571000},"page":"117243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Platform analytical procedure for the analysis of residual solvents in active pharmaceutical ingredients by headspace-gas chromatography \u2013 A use case of implementation"],"prefix":"10.1016","volume":"269","author":[{"given":"Nhung","family":"Dang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bohlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4057-5385","authenticated-orcid":false,"given":"Mikael","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117243_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.trac.2015.09.008","article-title":"Analytical procedures for quality control of pharmaceuticals in terms of residual solvents content: challenges and recent developments","volume":"80","author":"Tankiewicz","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117243_bib2","unstructured":"ICH, ICH Q3C (R9) Guideline on impurities: guideline for residual solvents, 2024. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q3c-r9-guideline-impurities-guideline-residual-solvents-step-5_en.pdf\u3009 (accessed June 13, 2025)."},{"key":"10.1016\/j.jpba.2025.117243_bib3","unstructured":"USP, \u3008467\u3009 Residual Solvents, 2022."},{"key":"10.1016\/j.jpba.2025.117243_bib4","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1016\/j.chroma.2010.08.016","article-title":"A generic static headspace gas chromatography method for determination of residual solvents in drug substance","volume":"1217","author":"Cheng","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2025.117243_bib5","article-title":"A generic headspace GC method for residual solvents in pharmaceuticals: benefits, rationale, and adaptations for new chemical entities","volume":"28","author":"Dai","year":"2010","journal-title":"LCGC North Am."},{"key":"10.1016\/j.jpba.2025.117243_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115349","article-title":"Platform headspace gas chromatography method for high-throughput determination of residual solvents in pharmaceutical materials","volume":"229","author":"Zou","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117243_bib7","unstructured":"ICH, ICH Q14 Guideline on analytical procedure development, 2024. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q14-guideline-analytical-procedure-development-step-5_en.pdf\u3009 (accessed June 13, 2025)."},{"key":"10.1016\/j.jpba.2025.117243_bib8","unstructured":"USP, \u30081220\u3009 Analytical Procedure Life Cycle, 2022."},{"key":"10.1016\/j.jpba.2025.117243_bib9","unstructured":"ICH Q2(R2) guideline on validation of analytical procedures, 2024. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q2r2-guideline-validation-analytical-procedures-step-5-revision-1_en.pdf\u3009 (accessed June 13, 2025)."},{"key":"10.1016\/j.jpba.2025.117243_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/acs.analchem.4c04521","article-title":"A modern framework for analytical procedure development and lifecycle management based on ICH Q14 Principles","volume":"97","author":"Eberle","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117243_bib11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jpba.2017.05.006","article-title":"An overview of experimental designs in HPLC method development and validation","volume":"147","author":"Sahu","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117243_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpba.2017.06.020","article-title":"Life cycle management of analytical methods","volume":"147","author":"Parr","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117243_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jpba.2018.07.050","article-title":"Risk-based approach for method development in pharmaceutical quality control context: a critical review","volume":"161","author":"Deidda","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117243_bib14","first-page":"2561","article-title":"The impact of analytical quality by design (AQBD) In the method development of liquid chromatography for quality control of pharmaceuticals: a review","author":"Shaha","year":"2019","journal-title":"IJSRR 2019"},{"key":"10.1016\/j.jpba.2025.117243_bib15","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-022-00685-2","article-title":"Analytical quality by design, life cycle management, and method control","volume":"24","author":"Verch","year":"2022","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2025.117243_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7324\/JAPS.2019.90604","article-title":"Development and validation of a stability-indicating RP-HPLC method of cholecalciferol in bulk and pharmaceutical formulations: analytical quality by design approach","volume":"9","author":"Suryawanshi","year":"2019","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.117243_bib17","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1021\/acs.oprd.9b00238","article-title":"Development and optimization of liquid chromatography analytical methods by using AQbD principles: overview and recent advances","volume":"23","author":"Tome","year":"2019","journal-title":"Org. Process Res Dev."},{"key":"10.1016\/j.jpba.2025.117243_bib18","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1021\/acs.analchem.8b04596","article-title":"Using the analytical target profile to drive the analytical method lifecycle","volume":"91","author":"Jackson","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117243_bib19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/acs.analchem.1c03854","article-title":"Selection of analytical technology and development of analytical procedures using the analytical target profile","volume":"94","author":"Borman","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117243_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.chroma.2006.12.046","article-title":"Analysis of class 1 residual solvents in pharmaceuticals using headspace-programmed temperature vaporization-fast gas chromatography-mass spectrometry","volume":"1141","author":"P\u00e9rez Pav\u00f3n","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2025.117243_bib21","unstructured":"USP, <1225>Validation of Compendial Methods, 2017."},{"key":"10.1016\/j.jpba.2025.117243_bib22","unstructured":"USP, \u30081467\u3009 Residual Solvents\u2014Verification of Compendial Procedures and Validation of Alternative Procedures, 2020."},{"key":"10.1016\/j.jpba.2025.117243_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.greeac.2025.100255","article-title":"Nitrogen and hydrogen as alternatives to helium using wide-bore columns in preparative multidimensional gas chromatography","volume":"13","author":"Cucinotta","year":"2025","journal-title":"Green. Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117243_bib24","unstructured":"L. Eriksson, E. Johansson, N. Kettaneh-Wold, C. Wikstr\u00f6m, S. Wold, Design of Experiments Principles and Applications, Third edition, 2008, Umetrix, ISBN-10:91-973730-4-4."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:40:19Z","timestamp":1764765619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525005849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":24,"alternative-id":["S0731708525005849"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117243","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platform analytical procedure for the analysis of residual solvents in active pharmaceutical ingredients by headspace-gas chromatography \u2013 A use case of implementation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117243"}}